DOCSLIB.ORG

ASDP 47Th Annual Meeting the American Society of Dermatopathology

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
ASDP 47Th Annual Meeting the American Society of Dermatopathology ASDP 47th Annual Meeting The American Society of Dermatopathology October 7–10, 2010 Program Hilton Atlanta & Abstracts Atlanta, GA USA www.asdp.org The American Society of Dermatopathology The American Society of Dermatopathology Table of Contents General Information . 5 2010 Founders’ and Nickel Award Recipients . 7 Officers, Committees, Program Directors . 9 Past Presidents, Past Secretary Treasurers, Past Editors . 10 Committee Meetings . 12 Faculty Disclosures . 13 Schedules at a Glance Program at a Glance . 17 Consultations in Dermatopathology . 20 Schedule at a Glance . 20 Self-Assessment in Dermatopathology . 22 Schedule at a Glance . 22 Exhibits and Supporters Exhibit Floor Plan . 25 Exhibitors and Supporters . 25 Thursday, October 7 Daily Program . 31 Session Handouts . 37 Friday, October 8 Daily Program . 41 President’s Reception & Banquet . 46 Session Handouts . 47 Saturday, October 9 Daily Program . 51 Memorial Lecture . 54 Evening Slide Symposium Case Summaries . 57 Session Handouts . 59 Sunday, October 10 Daily Program . 63 Session Handouts . 67 Oral Abstracts . 71 Poster Abstracts . 95 Presenter Index . 195 ASDP 47th Annual Meeting The American Society of Dermatopathology ASDP 47th Annual Meeting 1 www.asdp.org The American Society of Dermatopathology The American Society of Dermatopathology • Differentiate essential diagnostic features that lead to the General Information accurate histologic assessment of surgical margins . Continuing Medical Education • Recognize light microscopic findings that lead to a diagnosis of The American Society of Dermatopathology is accredited by the specific inflammatory dermatoses . Accreditation Council for Continuing Medical Education to provide • Develop a diagnostic approach to the evaluation of biopsies continuing medical education for physicians .The American Soci- from inflammatory skin lesions . ety of Dermatopathology designates this educational activity for • Expand diagnostic skills by increasing familiarity with a variety of a maximum of 35 AMA PRA Category 1 Credits™ . Physicians skin conditions . should only claim credit commensurate with the extent of their participation in the activity . • Recognize areas where new information gained from the pre- sented cases has identified potential practice gaps and altered The American Society of Dermatopathology 47th Annual Meeting your awareness of competence and performance related to the is recognized by the American Academy of Dermatology for 35 presented cases . hours of AAD Category I CME credit and may be used toward the American Academy of Dermatology’s Continuing Medical Educa- • Develop a differential diagnosis and diagnostic approach for tion Award . select groups of diseases by personal instruction with an expert in the field . CME Claims and Verification of Attendance • Self-assess your diagnostic acumen and relate this information to your daily practice . You will receive a CME Claim form in your registration packet on which you are to indicate the number of CME hours you are claim- Disclosure ing for this educational activity . The number of CME credit available for each course is indicated by the course title in this program and The American Society of Dermatopathology (ASDP) is accredited on the CME Claim form . Complete this form and submit it along by the Accreditation Council for Continuing Medical Education with your session evaluation forms to the ASDP meeting registra- (ACCME) . As such, we are require to meet the ACCME’s expec- tion desk . You must return this form in order to receive appropriate tations for our practice of continuing medical education . It is the CME credit . policy of the ASDP to ensure balance, independence, objectiv- ity and scientific rigor in all of its educational activities . Faculty Your self-claimed CME credits will be recorded after the Annual participating in and planning the Annual Meeting must comply with Meeting and an official CME certificate will be mailed to you . Allow all procedures governing disclosure . The ASDP has implemented a six to eight weeks for processing . Appropriate credit for atten- process where everyone in a position to control the content of an dance should be ascertained and reported by individual physicians educational activity will present evidence based content, disclose to the particular state or medical society to which he/she belongs . all relevant financial relationships with any commercial interest For those who are registered in the AAD CME Transcript/Award and discussion of unlabeled/investigational uses of a commercial Program, you should log in to the AAD Online CME Transcript product . In addition, presentations must be free of commercial bias Program to enter credits for this AAD recognized Category 1 CME and any information regarding commercial products/services must Program . ASDP’s AAD program number is 254-100 . be based on scientific methods generally accepted by the medical community . Conflicts will be resolved prior to this educational activ- Participant Objectives ity . Faculty who refuse to disclose relevant financial relationships and discussion of unlabeled/investigational uses of a commercial The mission of the American Society of Dermatopathology is to product may be disqualified from being a part of the planning and teach, aid in the dissemination of knowledge, and encourage re- implementation of this CME activity . Presenters who qualify for the search, thus improving the quality of the practice of dermatopathol- implementation of this activity are required to disclose to the audi- ogy . The annual meeting is primarily an educational one, offering ence, any of the relationships mentioned above . physicians, fellows, residents, and medical students, lectures on current topics in dermatopathology, interactive sessions at the mi- croscope, a self-assessment course, and opportunities for poster and abstract presentations . Overall Learning Objectives for the 2010 Annual Meeting: • Define molecular studies and other new techniques that are use- ful in confirming a diagnosis of infectious dermatoses . • Understand how histology, molecular studies and the application of new research techniques can be integrated to assist in the diagnosis of lymphoproliferative diseases . • Recognize new classification schemes for lymphoproliferative disorders . • Identify critical elements that lead to the histologic diagnosis of melanoma . ASDP 47th Annual Meeting 5 www.asdp.org The American Society of Dermatopathology The American Society of Dermatopathology Slide Library Room 209-211 Curator: Arthur K . Balin, MD, PhD, Sally Balin Medical Center for Dermatology & Cosmetic Surgery The ASDP Slide Library opens Friday, October 8, at 1:30 p .m . and will be open 24-hours-a-day through Sunday, October 10, at 11:00 a .m . One hundred selected cases from the continuously growing slide library will be available for microscopic examination . Cases are accompa- nied by the diagnosis and other relevant written information and references . The 2010 Slide Library handout with case summaries, diagno- ses with discussion and references will be available inside the library room . Upon completion of study, participants should be able to: • Explain the histologic diagnosis of various skin conditions, including the use of ancillary studies, where appropriate. • Interpret the histologic diagnosis of uncommon skin diseases. • Critique cases that highlight diagnostic challenges. • Apply morphological criteria to the differential diagnosis of cutaneous lesions. • Develop appropriate differential diagnoses for a wide spectrum of tumors and dermatoses. Membership Business Meeting Saturday, October 9 Salon East Ballroom Noon – 1:30 p .m . Members should attend the ASDP Membership Business Meeting luncheon on Saturday, October 9 . The annual report to the membership will be distributed to each meeting participant . Only Fellow members of the society are allowed to vote . Evening Slide Symposium Preview — Open 24 Hours! Room 213 Preview the Evening Slide Symposium cases throughout the annual meeting and attend the Symposium Saturday evening . Case summaries are listed in the program book behind the Saturday tab . ASDP Career Center Grand Ballroom Foyer The official ASDP career center is located on the Web site at www .asdp .org; however, the Society has employment boards located in the Grand Ballroom Foyer . Meeting registrants can post positions available or resumes for other attendees to peruse . Individuals are respon- sible for making copies . The Society will not make copies onsite . ASDP 47th Annual Meeting 6 www.asdp.org The American Society of Dermatopathology The American Society of Dermatopathology Annual Award Recipients 2010 Founders’ Award Daniel J. Santa Cruz, MD Cutaneous Pathology WCP Laboratories Inc The Founders’ Award honors individuals who have made significant contributions to the field of dermato- pathology, recognized by dermatopathologists throughout the medical world . This year the award will be presented to Daniel J . Santa Cruz, MD, in recognition of his leadership in the field of dermatopathology . Dr . Santa Cruz received his MD degree from the University of Buenos Aires, Buenos Aires, Argentina. His pa- thology residency and fellowship training was completed at Ohio State University and Washington University School of Medicine and Barnes Hospital in St . Louis, Missouri . In 1996, Dr . Santa Cruz and Dr Mark A . Hurt established Cutaneous Pathology (WCP Pathology Laboratories) in St Louis, MO . Over three hundred medi- cal students,
Load more

Recommended publications
  • Experience with Molluscum Contagiosum and Associated Inflammatory Reactions in a Pediatric Dermatology Practice the Bump That Rashes
    STUDY ONLINE FIRST Experience With Molluscum Contagiosum and Associated Inflammatory Reactions in a Pediatric Dermatology Practice The Bump That Rashes Emily M. Berger, MD; Seth J. Orlow, MD, PhD; Rishi R. Patel, MD; Julie V. Schaffer, MD Objective: To investigate the frequency, epidemiol- (50.6% vs 31.8%; PϽ.001). In patients with molluscum ogy, clinical features, and prognostic significance of in- dermatitis, numbers of MC lesions increased during the flamed molluscum contagiosum (MC) lesions, mollus- next 3 months in 23.4% of those treated with a topical cum dermatitis, reactive papular eruptions resembling corticosteroid and 33.3% of those not treated with a topi- Gianotti-Crosti syndrome, and atopic dermatitis in pa- cal corticosteroid, compared with 16.8% of patients with- tients with MC. out dermatitis. Patients with inflamed MC lesions were less likely to have an increased number of MC lesions Design: Retrospective medical chart review. over the next 3 months than patients without inflamed MC lesions or dermatitis (5.2% vs 18.4%; PϽ.03). The Setting: University-based pediatric dermatology practice. GCLRs were associated with inflamed MC lesion (PϽ.001), favored the elbows and knees, tended to be Patients: A total of 696 patients (mean age, 5.5 years) pruritic, and often heralded resolution of MC. Two pa- with molluscum. tients developed unilateral laterothoracic exanthem– like eruptions. Main Outcome Measures: Frequencies, characteris- tics, and associated features of inflammatory reactions Conclusions: Inflammatory reactions to MC, including to MC in patients with and without atopic dermatitis. the previously underrecognized GCLR, are common. Treat- ment of molluscum dermatitis can reduce spread of MC Results: Molluscum dermatitis, inflamed MC lesions, and via autoinoculation from scratching, whereas inflamed MC Gianotti-Crosti syndrome–like reactions (GCLRs) oc- lesions and GCLRs reflect cell-mediated immune re- curred in 270 (38.8%), 155 (22.3%), and 34 (4.9%) of sponses that may lead to viral clearance.
    [Show full text]
  • Updates in Pediatric Dermatology
    Peds Derm Updates ELIZABETH ( LISA) SWANSON , M D ADVANCED DERMATOLOGY COLORADO ROCKY MOUNTAIN HOSPITAL FOR CHILDREN [email protected] Disclosures Speaker Sanofi Regeneron Amgen Almirall Pfizer Advisory Board Janssen Powerpoints are the peacocks of the business world; all show, no meat. — Dwight Schrute, The Office What’s New In Atopic Dermatitis? Impact of Atopic Dermatitis Eczema causes stress, sleeplessness, discomfort and worry for the entire family Treating one patient with eczema is an example of “trickle down” healthcare Patients with eczema have increased risk of: ADHD Anxiety and Depression Suicidal Ideation Parental depression Osteoporosis and osteopenia (due to steroids, decreased exercise, and chronic inflammation) Impact of Atopic Dermatitis Sleep disturbances are a really big deal Parents of kids with atopic dermatitis lose an average of 1-1.5 hours of sleep a night Even when they sleep, kids with atopic dermatitis don’t get good sleep Don’t enter REM as much or as long Growth hormone is secreted in REM (JAAD Feb 2018) Atopic Dermatitis and Food Allergies Growing evidence that food allergies might actually be caused by atopic dermatitis Impaired barrier allows food proteins to abnormally enter the body and stimulate allergy Avoiding foods can be harmful Proper nutrition is important Avoidance now linked to increased risk for allergy and anaphylaxis Refer severe eczema patients to Allergist before 4-6 mos of age to talk about food introduction Pathogenesis of Atopic Dermatitis Skin barrier
    [Show full text]
  • Atopic Dermatitis (Eczema) •Chronic Inflammatory Skin Disease That Begins During Infancy Or Early Childhood
    9/18/2019 Pediatric Dermatology Jennifer Abrahams, MD, FAAD, DTM&H Collaborators: Kate Oberlin, MD; Nayoung Lee MD September 27th, 2019 1 Disclosures • Nothing to disclose 2 1 9/18/2019 Disclaimer *Pediatric dermatology is taught over 3 years of derm-specific residency training and there is an additional year of subspecialized fellowship! *We won’t cover all of pediatric derm in an hour but I hope to give you some common highlights 3 A 9 month old infant presents with the following skin lesions. Which of the following is most likely true of this disease? A.) Asthma generally precedes skin findings B.) The majority of affected children will outgrow the skin disease C.) There is no way to avoid or decrease risk of progression of the disease D.) Genetic factors account for approx 1% of susceptibility to early onset of this disease 4 2 9/18/2019 A 9 month old infant presents with the following skin lesions. Which of the following is most likely true of this disease? A.) Asthma generally precedes skin findings B.) The majority of affected children will outgrow the skin disease C.) There is no way to avoid or decrease risk of progression of the disease D.) Genetic factors account for approx 1% of susceptibility to early onset of this disease 5 6 3 9/18/2019 Atopic Dermatitis (Eczema) •Chronic inflammatory skin disease that begins during infancy or early childhood •Often associated with other “atopic” disorders • Asthma • Allergic rhinitis (seasonal allergies) • Food allergies •Characterized by intense itch and a chronic relapsing course •Prevalence almost 30% in developed countries 7 Table courtesy of Bolognia, et al.
    [Show full text]
  • Bbm:978-3-642-38765-4/1.Pdf
    Index A Becker nevus and Becker nevus syndrome , Acantholysis, transient superfi cial , 158–159 14, 15, 86, 88–90 Acanthosis nigricans , 19, 20, 141–142, 145, 146 BFH. See Basaloid follicular hamartoma (BFH) Acne nevus of Munro , 91 Binary genodermatoses , 23, 115–118 Acne vulgaris , 26, 200–201, 203 aplasia cutis congenita Acrokeratoelastoidosis , 146 and nevus psiloliparus , 116, 117 AHO. See Albright’s hereditary osteodystrophy (AHO) and nevus sebaceous , 116 Aicardi syndrome , 188–189 nevus sebaceus and melorheostosis , 116 AKT1 mutation , 79, 83, 137 phacomatosis pigmentokeratotica , 115–116 Albinism-deafness syndrome, X-linked , 189–191 phacomatosis pigmentovascularis , 116–118 Albinism, X-linked oculocutaneous , 54 Birt-Hogg-Dubé syndrome. See Hornstein-Knickenberg Albright’s hereditary osteodystrophy (AHO) , 19, 20, syndrome 151–154 Blaschkitis , 49, 195, 205, 208 Allelic didymosis , 23–24, 109–111 Blaschko, Alfred , 9, 45, 47–51 capillary didymosis , 109–111 Blaschko dermatitis , 195 cutis tricolor , 110–111 Blaschko’s lines , 45–59, 63–64, 74 Darier disease , 111, 112 analogous patterns in other organs , 53–58 epidermolytic ichthyosis of Brocq , 111 in animals , 51, 54–56 Amelogenesis imperfecta , 53 atypical lines , 63–64 Anemic halo. See Rhodoid nevus brindle trait , 51, 54, 55 Angiokeratoma circumscriptum , 96 in broad bands , 46, 52–53 Angioma serpiginosum , 96–97 in chimeric mice , 51, 54 Angora hair nevus , 15, 86, 88–89 dwarf zebu, brindle trait , 54, 55 Apert syndrome , 91 embryonic cells , 49, 50 Archetypical patterns , 45–59 in epidermal nevi , 50, 52 Arteriovenous fi stulas , 20, 138, 156 on head and neck , 47, 50 Art nouveau , 57 intraoral lesions , 52 Atopic dermatitis , 26, 194, 195, 197–199 murine brain , 54, 56 ATP7A gene , 188 in narrow bands , 52 ATP2C1 mutation.
    [Show full text]
  • An Open, Randomized, Comparative Clinical and Histological Study Of
    Ann Dermatol Vol. 22, No. 2, 2010 DOI: 10.5021/ad.2010.22.2.156 ORIGINAL ARTICLE An Open, Randomized, Comparative Clinical and Histological Study of Imiquimod 5% Cream Versus 10% Potassium Hydroxide Solution in the Treatment of Molluscum Contagiosum Sang-Hee Seo, M.D., Hyun-Woo Chin, M.D., Dong-Wook Jeong, M.D.1, Hyun-Woo Sung, M.D.2 Departments of Dermatology and 1Family Medicine, Yansan Pusan National University Hospital, School of Medicine, Pusan National University, Yangsan, 2Department of Orthopaedics, School of Medicine, Dong-a University Medical Center, Busan, Korea Background: Although molluscum contagiosum (MC) re- -Keywords- solves spontaneously, there are several reasons to treat this Imiquimod, Molluscum contagiosum, Potassium hydrox- dermatological disorder. Objective: To evaluate the safety ide and efficacy of 5% imiquimod cream versus 10% potassium hydroxide (KOH) solution in treating MC, and to propose the mechanism of cure by observing the histological findings. INTRODUCTION Methods: Imiquimod or KOH were applied by the patient or a parent 3 days per week until all lesions cleared. The Molluscum contagiosum (MC), the most common viral number of MC lesions was counted and side effects were skin infections (2∼8%) in children, is a self-limiting evaluated at 5 points during the treatment (the initial visit, epidermal papular condition caused by the Molluscipox week 2, week 4, week 8, and week 12). Histological changes virus1. Although spontaneous resolution of the lesions were compared between 2 patients of each group, before occurs, there are several reasons to treat them2. Firstly, the and after the 2 weeks of application. Results: In both group, lesions are cosmetically unattractive.
    [Show full text]
  • Laser Therapy for the Treatment of Morphea: a Systematic Review of Literature
    Journal of Clinical Medicine Review Laser Therapy for the Treatment of Morphea: A Systematic Review of Literature Paulina Szczepanik-Kułak * , Małgorzata Michalska-Jakubus and Dorota Krasowska Chair and Department of Dermatology, Venerology and Paediatric Dermatology, Medical University of Lublin, 20-081 Lublin, Poland; [email protected] (M.M.-J.); [email protected] (D.K.) * Correspondence: [email protected] Abstract: Morphea, also known as localized scleroderma (LoS), comprises a set of autoimmune sclerotic skin diseases. It is characterized by inflammation and limited thickening and induration of the skin; however, in some cases, deeper tissues might also be involved. Although morphea is not considered a life-threatening disease, the apparent cosmetic disfigurement, functional or psychosocial impairment affects multiple fields of patients’ quality of life. Therapy for LoS is often unsatisfactory with numerous treatments that have only limited effectiveness or considerable side effects. Due to the advances in the application of lasers and their possible beneficial effects, the aim of this study is to review the reported usage of laser in morphea. We present a systematic review of available literature, performed with MEDLINE, Cinahl, Central, Scopus, Web of Science, and Google Scholar databases. We identified a total of twenty relevant studies (MEDLINE n = 10, Cinahl n = 1, Central n = 0, Scopus n = 2, Web of Science n = 5, Google Scholar n = 2) using laser therapy for LoS. Eight studies were focused on the use of PDL, six on fractional lasers (CO2 and Er:YAG), four on excimer, and two on either alexandrite or Nd:YAG. Keywords: morphea; localized scleroderma; laser therapy Citation: Szczepanik-Kułak, P.; Michalska-Jakubus, M.; Krasowska, D.
    [Show full text]
  • Gr up SM Skin In
    SMGr up Skin in HIV Title: Skin in HIV Editor: Leelavathy Budamakuntla Published by SM Online Publishers LLC Copyright © 2015 SM Online Publishers LLC ISBN: 978-0-9962745-2-4 All book chapters are Open Access distributed under the Creative Commons Attribution 3.0 license, which allows users to download, copy and build upon published articles even for commercial purposes, as long as the author and publisher are properly credited, which ensures maximum dissemination and a wider impact of the publication. Upon publication of the eBook, authors have the right to republish it, in whole or part, in any publication of which they are the author, and to make other personal use of the work, identifying the original source. Statements and opinions expressed in the book are these of the individual contributors and not necessarily those of the editors or publisher. No responsibility is accepted for the accuracy of information contained in the published chapters. The publisher assumes no responsibility for any damage or injury to persons or property arising out of the use of any materials, instructions, methods or ideas contained in the book. First published April, 2015 Online Edition available at http://www.smgebooks.com For reprints, please contact us at [email protected] Skin in HIV | www.smgebooks.com 1 SMGr up Cutaneous Infections in HIV Disease Eswari L and Merin Paul P Department of Dermatology, STD and Leprosy, Bangalore Medical College and Research Institute, India. *Corresponding author: Leelavathy B, Department of Dermatology, STD and Leprosy, Bow- ring and Lady Curzon Hospital, Bangalore Medical College and Research Institute, Bengaluru, Karnataka, India, Email: [email protected] Published Date: April 15, 2015 INTRODUCTION Diagnosing and managing cutaneous infections in a HIV positive patient is a formidable and challenging task.
    [Show full text]
  • Treatment of Molluscum Contagiosum by Potassium Hydroxide Solution 20% with and Without Pricking and by Pricking Alone: a Comparative Study with Review of Literature
    International Journal of Dermatology and Clinical Research Azar Hadi Maluki1* and Qutaiba Jawad Research Article Kadhum2 1Professor, Department of Dermatology, College of Medicine, University of Kufa, Iraq Treatment of Molluscum 2Department of Dermatology, Kufa Medical School Teaching Hospital, Iraq Contagiosum by Potassium Dates: Received: 04 December, 2015; Accepted: 26 December, 2015; Published: 28 December, 2015 Hydroxide Solution 20% with and *Corresponding author: Prof. Dr. Azar H. Maluki, P.O. Box (450), AL-Najaf Post Office, Iraq, Tel: (+964)7802887712; E-mail: Without Pricking and By Pricking www.peertechz.com Alone: A Comparative Study with ISSN: 2455-8605 Review of Literature Abstract Background: Molluscum Contagiosum is a common viral skin infection, caused by poxvirus, commonly affects young children. Although there is no specific treatment for this infection, many therapeutic modalities has been used with different success rates. Objectives: To evaluate the effectiveness of topical 20% KOH, 20% KOH with pricking and pricking alone as comparative treatments for molluscum contagiosum. Patients and methods: This study was conducted in the Dermatology Clinic of Kufa Medical School Teaching Hospital in Iraq, from August 2011 to January 2013. Ninety patients with Molluscum Contagiosum were recruited. Diagnosis of Molluscum Contagiosum was confirmed on clinical bases. Patients with prior treatment for the last month and patients who had inflamed lesions were excluded. Full history and physical examination were done for all Patients. The patients were divided into three groups: Group 1included 30 patients treated with topical KOH 20% applied by wooden stick daily at bed time. Group 2 included 30 patients treated by pricking the lesions by 27 G needle wet in 20% KOH weekly.
    [Show full text]
  • The Classification of Capillary Malformations
    The classification of capillary malformations Dubrovnik 3 May 2019 Rudolf Happle Department of Dermatology University of Freiburg Germany Background:: The unsuitable classification of the International Society for the Study of Vascular Anomalies (ISSVA) The unsuitable classification of the ISSVA Capillary malformation Capillary malformation Capillary malformation Capillary malformation Capillary malformation Vascular Anomalies Classification: Recommendations From the International Society for the Study of Vascular Anomalies Wassef M et al and ISSVA Board and Scientific Committee: Pediatrics 2015 Klippel-Trenaunay syndrome: CM + VM +/− LM + limb overgrowth Parkes-Weber syndrome: CM + AVF + limb overgrowth Servelle-Martorell syndrome: limb VM + bone undergrowth Sturge-Weber syndrome: facial + leptomeningeal CM + ocular anomalies +/− bone and/or soft tissue overgrowth Limb CM + congenital nonprogressive limb hypertrophy Maffucci syndrome: VM +/− spindle cell hemangioma + enchondroma Macrocephaly-CM (M-CM)/megalencephaly-CM-polymicrogyria (MCAP) Microcephaly-CM (MICCAP) CLOVES syndrome: LM + VM + CM +/− AVM + lipomatous overgrowth Proteus syndrome: CM, VM and/or LM + asymmetric somatic overgrowth Bannayan-Riley-Ruvalcaba syndrome: AVM + VM + macrocephaly, lipomatous overgrowth Approved in Amsterdam, May 2018 For pediatric dermatologists, this classification is useless! http://www.issva.org/classification All of these capillary nevi may occur without any extracutaneous abnormality! Nevus flammeus Nevus roseus Rhodoid nevus Nevus vascularis
    [Show full text]
  • Mallory Prelims 27/1/05 1:16 Pm Page I
    Mallory Prelims 27/1/05 1:16 pm Page i Illustrated Manual of Pediatric Dermatology Mallory Prelims 27/1/05 1:16 pm Page ii Mallory Prelims 27/1/05 1:16 pm Page iii Illustrated Manual of Pediatric Dermatology Diagnosis and Management Susan Bayliss Mallory MD Professor of Internal Medicine/Division of Dermatology and Department of Pediatrics Washington University School of Medicine Director, Pediatric Dermatology St. Louis Children’s Hospital St. Louis, Missouri, USA Alanna Bree MD St. Louis University Director, Pediatric Dermatology Cardinal Glennon Children’s Hospital St. Louis, Missouri, USA Peggy Chern MD Department of Internal Medicine/Division of Dermatology and Department of Pediatrics Washington University School of Medicine St. Louis, Missouri, USA Mallory Prelims 27/1/05 1:16 pm Page iv © 2005 Taylor & Francis, an imprint of the Taylor & Francis Group First published in the United Kingdom in 2005 by Taylor & Francis, an imprint of the Taylor & Francis Group, 2 Park Square, Milton Park Abingdon, Oxon OX14 4RN, UK Tel: +44 (0) 20 7017 6000 Fax: +44 (0) 20 7017 6699 Website: www.tandf.co.uk All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without the prior permission of the publisher or in accordance with the provisions of the Copyright, Designs and Patents Act 1988 or under the terms of any licence permitting limited copying issued by the Copyright Licensing Agency, 90 Tottenham Court Road, London W1P 0LP. Although every effort has been made to ensure that all owners of copyright material have been acknowledged in this publication, we would be glad to acknowledge in subsequent reprints or editions any omissions brought to our attention.
    [Show full text]
  • Fig. 1. Lentigo Simplex. Elongated Rete Ridges, Hyperpigmentation of The
    97 Fig. 1. Lentigo simplex. Elongated rete ridges, hyperpigmentation of the basal layer and increase in number of enlarged melanocytes arranged singly along the basal layer Fig. 2. Junctional melanocytic naevus. Nests of melanocytes are present at the dermo-epidermal junction, predominantly at the bases of elongated rete ridges 98 a b Fig.3a,b. Compound melanocytic naevus. a Nests of melanocytes in the dermis as well as the derma-epidermal junction, smaller and more diffusely arranged in the deeper dermis. b The nests of melanocytes include multinucleated giant cells 99 Fig. 4. Dermal melanocytic naevus. Entirely intradermal tumour in a nested pattern in the superficial layers, composed of small naevoid melanocytes in the deep dermis Fig. 5. Dermal melanocytic naevus. The deeper layers of this dermal melanocytic naevus include neuroid structures similar to Wagner-Meissner corpuscles (neuroid dermal melanocytic naevus) 100 Fig. 6. Balloon cell naevus. The tumour is composed mainly of melanocytes with abundant clear cytoplasm and central nuclei Fig. 7. Halo naevus. Compound naevus with a dense lymphocytic infiltrate between the naevoid melanocytes of the dermal component Fig. 8. Combined intradermal naevus and blue naevus. Nests of epithelioid naevus cells in the dermis (right) and heavily pigmented spindle and dendritic cells arranged between collagen bundles in the adjacent stroma (left) Fig. 9a. Deep penetrating naevus. A wedge-shaped lesion composed of irregu­ lar collections of variably pigmented cells extending into the deep dermis. 102 Fig. 9b. Deep penetrating naevus. In the deep dermis the lesion includes large cells with nuclear pseudo-inclusions, smaller naevoid melanocytes and groups of melanophages in the intervening stroma Fig.
    [Show full text]
  • Pigmented Purpuric Dermatosis: a Review of the Literatureଝ
    Actas Dermosifiliogr. 2020;111(3):196---204 REVIEW Pigmented Purpuric Dermatosis: A Review of the Literatureଝ ∗ I. Martínez Pallás, R. Conejero del Mazo, V. Lezcano Biosca Servicio de Dermatología y Venereología, Hospital Clínico Lozano Blesa, Zaragoza, Spain Received 21 October 2018; accepted 24 February 2019 Available online 20 March 2020 KEYWORDS Abstract The pigmented purpuric dermatoses (PPDs) are a group of benign, chronic diseases. The variants described to date represent different clinical presentations of the same entity, Purpuric pigmented dermatosis; all having similar histopathologic characteristics. We provide an overview of the most common Review; PPDs and describe their clinical, dermatopathologic, and epiluminescence features. PPDs are both rare and benign, and this, together with an as yet poor understanding of the pathogenic Clinical presentation; Treatment mechanisms involved, means that no standardized treatments exist. We review the treatments described to date. However, because most of the descriptions are based on isolated cases or small series, there is insufficient evidence to support the use of any of these treatments as first-line therapy. © 2019 AEDV. Published by Elsevier Espana,˜ S.L.U. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). PALABRAS CLAVE Dermatosis purpúricas pigmentadas. Revisión de la literatura científica Dermatosis purpúrico pigmentadas; Resumen Las dermatosis purpúrico pigmentadas (DPP) son un grupo de enfermedades benig- Revisión; nas y de curso crónico. Las variantes descritas representan distintas formas clínicas de una misma entidad con unas características histopatológicas comunes para todas ellas. Exponemos Presentación clínica; Tratamiento a continuación un resumen de las variedades más frecuentes, sus características clínicas, der- matopatológicas y de epiluminiscencia.
    [Show full text]